Efficacy and safety of an interferon-free regimen of MK-5172+ribavirin for 12 Weeks or 24 weeks in treatment naive, non-cirrhotic subjects with HCV GT1 infection: The C-SPIRIT study

Authors
Category Primary study
ConferenceHepatology
Year 2013
This article has no abstract
Epistemonikos ID: 4fba26209385855e6024e0870d77ba19761911af
First added on: Apr 30, 2026